Literature DB >> 20124933

Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004.

William T Curry1, Bob S Carter, Fred G Barker.   

Abstract

OBJECTIVE: Racial disparities in American health care outcomes are well documented. We investigated racial disparities in hospital mortality and adverse discharge disposition after brain tumor craniotomies performed in the United States from 1988 to 2004. We explored potential explanations for the disparities.
METHODS: The data source was the Nationwide Inpatient Sample. We used multivariate ordinal logistic regression corrected for clustering by hospital and adjusted for age, sex, primary payer for care, income in postal code of residence, geographic region, admission type and source, medical comorbidity, treatment year, hospital case volume, and disease-specific factors. Random-effects pooling was also used.
RESULTS: A total of 99 665 craniotomies were studied. Hospital mortality and adverse discharge disposition (any discharge other than directly home) were more likely in black patients than others for all tumor types. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for blacks were: hospital craniotomy mortality (OR, 1.64; 95% CI, 1.32-2.03; P < .001), and adverse discharge disposition (OR, 1.43; 95% CI, 1.31-1.56; P < .001). Medicaid patients had higher mortality, while private-pay patients had lower mortality. Hospital annual case volume was lower for black and Hispanic patients and for those with Medicaid as the primary payer in pooled analyses, whereas patients with private insurance received care at higher-volume hospitals. Black patients generally presented with higher disease severity, including more emergency or urgent admissions (OR, 1.71; 95% CI, 1.54-1.89; P < .001); more hemiparesis and hemiplegia for primary tumors, meningiomas, and metastases (P < .04 for all); and more hydrocephalus for acoustic neuromas (P = .1).
CONCLUSION: Black patients died more often or had an adverse discharge disposition after tumor craniotomies in the United States in the period studied (1988-2004). Blacks had more severe disease at presentation and were treated at lower-volume hospitals for surgery. Other socially defined patient groups also showed disparities in access and outcomes of care.

Entities:  

Mesh:

Year:  2010        PMID: 20124933     DOI: 10.1227/01.NEU.0000365265.10141.8E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  50 in total

1.  Disparities in health care determine prognosis in newly diagnosed glioblastoma.

Authors:  Ankush Chandra; Jonathan W Rick; Cecilia Dalle Ore; Darryl Lau; Alan T Nguyen; Diego Carrera; Alexander Bonte; Annette M Molinaro; Philip V Theodosopoulos; Michael W McDermott; Mitchel S Berger; Manish K Aghi
Journal:  Neurosurg Focus       Date:  2018-06       Impact factor: 4.047

2.  Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.

Authors:  Jacob Y Shin; Ja Kyoung Yoon; Aidnag Z Diaz
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

3.  Health insurance and the ongoing debate of quality and quantity.

Authors:  Robert Cavaliere
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

4.  The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease.

Authors:  Andres J Yarur; Maria T Abreu; Mark S Salem; Amar R Deshpande; Daniel A Sussman
Journal:  Dig Dis Sci       Date:  2013-03-13       Impact factor: 3.199

5.  Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Authors:  Haley Gittleman; David J Cote; Quinn T Ostrom; Carol Kruchko; Timothy R Smith; Elizabeth B Claus; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

6.  Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.

Authors:  Jacob Y Shin; Aidnag Z Diaz
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

7.  National Incidence of Patient Safety Indicators in the Total Hip Arthroplasty Population.

Authors:  Joseph E Tanenbaum; Derrick M Knapik; Glenn D Wera; Steven J Fitzgerald
Journal:  J Arthroplasty       Date:  2017-04-12       Impact factor: 4.757

8.  Poverty, insurance, and region as predictors of epilepsy treatment among US adults.

Authors:  Magdalena Szaflarski; Joseph D Wolfe; Joshua Gabriel S Tobias; Ismail Mohamed; Jerzy P Szaflarski
Journal:  Epilepsy Behav       Date:  2020-04-12       Impact factor: 2.937

9.  Disparities in reportable quality metrics by insurance status in the primary spine neoplasm population.

Authors:  Syed K Mehdi; Joseph E Tanenbaum; Vincent J Alentado; Jacob A Miller; Daniel Lubelski; Edward C Benzel; Thomas E Mroz
Journal:  Spine J       Date:  2016-09-21       Impact factor: 4.166

10.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.